You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR OLANZAPINE PAMOATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for OLANZAPINE PAMOATE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00320489 ↗	Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia	Completed	Eli Lilly and Company	Phase 3	2006-04-01	To compare the health outcome of patients with schizophrenia, who are at risk for relapse, when treated with a long acting injection form of olanzapine versus treatment with oral olanzapine.
NCT01389908 ↗	A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder	Unknown status	Shalvata Mental Health Center	N/A	2011-06-01	The purpose of this study is to assess the long-term efficacy of Olanzapine Pamoate (OP) Depot in patients diagnosed with schizophrenia or schizoaffective disorder.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for OLANZAPINE PAMOATE

Condition Name

Chart
Table

Condition Name for OLANZAPINE PAMOATE
Intervention	Trials
Schizophrenia	2
Schizoaffective Disorders	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for OLANZAPINE PAMOATE
Intervention	Trials
Schizophrenia	2
Psychotic Disorders	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for OLANZAPINE PAMOATE

Trials by Country

Map
Table

Trials by Country for OLANZAPINE PAMOATE
Location	Trials
United States	7
Canada	4
Argentina	1
Greece	1
Romania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for OLANZAPINE PAMOATE
Location	Trials
Ohio	1
New York	1
Illinois	1
Hawaii	1
District of Columbia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for OLANZAPINE PAMOATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for OLANZAPINE PAMOATE
Clinical Trial Phase	Trials
Phase 3	1
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for OLANZAPINE PAMOATE
Clinical Trial Phase	Trials
Completed	1
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for OLANZAPINE PAMOATE

Sponsor Name

Chart
Table

Sponsor Name for OLANZAPINE PAMOATE
Sponsor	Trials
Eli Lilly and Company	1
Shalvata Mental Health Center	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for OLANZAPINE PAMOATE
Sponsor	Trials
Industry	1
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.